Identification | Back Directory | [Name]
(3beta)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-N-[1-(4-chlorophenyl)cyclopropyl]-alpha,21-dioxo-28-norlup-18-ene-17-acetamide | [CAS]
1422355-59-6 | [Synonyms]
CS-2439 CS-2256 GSK 8999 GSK-8999 GSK2578999 GSK2578999(GSK8999) GSK-2578999;GSK-8999;GSK 2578999;GSK 8999;GSK 2578999A;GSK 2578999 (3beta)-3-(3-Carboxy-3-methyl-1-oxobutoxy)-N-[1-(4-chlorophenyl)cyclopropyl]-alpha,21-dioxo-28-norlup-18-ene-17-acetamide | [EINECS(EC#)]
604-604-1 | [Molecular Formula]
C46H62ClNO7 | [MDL Number]
MFCD30533317 | [MOL File]
1422355-59-6.mol | [Molecular Weight]
776.44 |
Hazard Information | Back Directory | [Description]
GSK2578999A is a betulin derivative as antitumor agent. | [target]
GSK2578999A is a betulin derivative as antitumor agent. |
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Website: |
www.bocsci.com |
Company Name: |
Cckinase, Inc.
|
Tel: |
+1 (732)236-3202 |
Website: |
www.cckinase.com |
|